Alphabet Stock Slides as Google AI Pioneer Jeff Dean Exits to Launch Discovery Loop 
SoftBank Q1 Profit Beats Forecast as Intel Rally and OpenAI Investments Boost Returns 
Glencore Posts Strong H1 2026 Earnings, Announces ASX Secondary Listing 
Western Digital Q4 Earnings Beat Estimates as FY2027 Outlook Tops Expectations 
Heineken H1 Operating Profit Meets Forecast as Beer Volumes Beat Expectations 
SpaceX Targets Starship Flight 14 With First V3 Starlink Satellite Launch 
DoorDash Q2 Revenue Jumps 36% as Orders and DashPass Growth Drive Results 
Alibaba Plans Revenue-Sharing Model for Qwen3.8-Max AI Commercial Users 
DeepSeek to Raise AI API Prices as Demand for New Models Surges 
Meta AI Model Exploits Security Flaw During Cybersecurity Test, Raising AI Safety Concerns 
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+ 
Infineon Raises 2026 Revenue Outlook as AI Data Center Demand Fuels Record Quarterly Sales 
AMP Shares Surge 13% After Strong Profit and A$150 Million Buyback 
SanDisk Q4 Earnings Beat Estimates as Q1 Revenue Outlook Meets Expectations 
Qantas Shares Climb as Long-Haul Pilot Deal Eases Strike Concerns 
DHL Q2 Profit Jumps 24% as Express Business Drives Growth 
ATLANTA, March 06, 2018 -- NFANT Labs has been named a finalist in the South by Southwest (SXSW) Impact Pediatric Health competition that will be held March 9th in Austin, TX.
Created four years ago by eight of the top U.S. News & World Report “Best Children’s Hospitals,” Impact Pediatric Health is a one-of-a-kind pitch competition to help showcase and support the best pediatric health care innovations. Representatives from all eight hospitals, as well as venture capitalists and industry leaders, will hear pitches from all of the finalists in order to choose an overall winner. This select group of companies will also have the opportunity to meet with hospitals one-on-one in order to foster relationships and implement solutions to solve real world problems.
NFANT Labs is uniquely suited for Impact’s area of focus this year: prematurity, digital health and medtech. NFANT Labs developed nfant Feeding Solution, the first FDA cleared IoT device for the NICU and most recently, nfant Analytics, a Machine Learning and reporting platform aimed at leveraging objective IoT data to help infants struggling to feed.
“It’s an honor to be chosen as a finalist for this prestigious award,” said Lou Malice, NFANT’s CEO. “With our products already implemented into hospitals across the country, NFANT is poised to make a large and immediate impact in the lives of these infants and their families. We are excited for the opportunity to work with these top-notch children’s hospitals to make predictive analytics a reality in neonatal feeding care.”
Participating hospitals include Children’s Healthcare of Atlanta, Boston Children’s Hospital, Cincinnati Children’s Hospital, Children’s Hospital Los Angeles, Children’s Hospital of Philadelphia, Seattle Children’s Hospital, Stanford Children’s Health and Texas Children’s Hospital.
About NFANT Labs
NFANT Labs is an emerging digital health and medical device company based in Atlanta, Georgia, dedicated to infant feeding. nfant Feeding Solution, the first FDA-cleared "Internet of Things" (IoT) medical device for the NICU, and nfant Analytics, a Machine Learning and reporting platform, give clinicians, hospital providers and payers insight to infant progress and path to discharge. Improving the standard of feeding care by collecting objective data and tracking feeding progression has the potential to shorten NICU stays, reduce readmissions and deliver substantial savings. For more information about NFANT Labs and all of its products please visit www.nfant.com.
Contact: [email protected] – 800.761.7601
